Clinical studies recruiting near Waterford

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM
Phase 2 · Smilow Cancer Hospital Care Center - Waterford · SWOG Cancer Research Network · NCT06769126 A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
Phase 3 · Michigan Dermatology Institute · Pfizer · NCT07029828 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Smilow Cancer Hospital Care Center - Waterford · NRG Oncology · NCT05174169 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Smilow Cancer Hospital Care Center - Waterford · Alliance for Clinical Trials in Oncology · NCT06876714 This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate
Phase N/A · Michigan Dermatology Institute - Waterford- Site Number : 84 · Sanofi · NCT07290803 Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene M
Phase 2 · Smilow Cancer Hospital Care Center - Waterford · SWOG Cancer Research Network · NCT05806515 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557 Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Deg
Phase 3 · Adverum Clinical Site 165 · Adverum Biotechnologies, Inc. · NCT07482176 A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary
Phase 3 · Retina Group of New England, PC · Kodiak Sciences Inc · NCT06990399 Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · Smilow Cancer Hospital Care Center - Waterford · National Cancer Institute (NCI) · NCT05256225 Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Phase 3 · Smilow Cancer Hospital Care Center - Waterford · ECOG-ACRIN Cancer Research Group · NCT04566328 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Smilow Cancer Hospital Care Center - Waterford · NRG Oncology · NCT04852887 Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Phase 2 · Retina Group of New England · ONL Therapeutics · NCT06659445 EXtubation Related Complications - the EXTUBE Study (EXTUBE)
Phase N/A · University Hospital Waterford · University Health Network, Toronto · NCT06442930 Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide,
Phase 3 · Smilow Cancer Hospital Care Center - Waterford · National Cancer Institute (NCI) · NCT06058377 Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
Phase 3 · University Hospital Waterford · European Organisation for Research and Treatment of Cancer - · NCT05512364 Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Phase 3 · Smilow Cancer Hospital Care Center - Waterford · Alliance for Clinical Trials in Oncology · NCT07215910 Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Phase N/A · Smilow Cancer Hospital Care Center - Waterford · ECOG-ACRIN Cancer Research Group · NCT04239573 Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · Smilow Cancer Hospital Care Center - Waterford · National Cancer Institute (NCI) · NCT05987241 Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
Phase 2 · Smilow Cancer Hospital Care Center - Waterford · SWOG Cancer Research Network · NCT04205968 Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to E
Phase 3 · The Institute of Eye Surgery · King's College Hospital NHS Trust · NCT04663750 Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combina
Phase 2/Phase 3 · University Hospital Waterford · Mirati Therapeutics Inc. · NCT04613596 A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Phase 3 · Smilow Cancer Hospital Care Center - Waterford · National Cancer Institute (NCI) · NCT05675410 Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head
Phase 2 · Smilow Cancer Hospital Care Center - Waterford · ECOG-ACRIN Cancer Research Group · NCT02734537 Testing the Effectiveness of a Work Rehabilitation Intervention for Women with Breast Cancer
NA · Solas Cancer Support Centre · University of Dublin, Trinity College · NCT06723899 Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had
Phase 2/Phase 3 · Smilow Cancer Hospital Care Center - Waterford · SWOG Cancer Research Network · NCT06616584 Extension Study for the Port Delivery System With Ranibizumab (Portal)
Phase 3 · Retina Group of New England · Hoffmann-La Roche · NCT03683251 A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab
Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT06679101 S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic
NA · Smilow Cancer Hospital Care Center - Waterford · SWOG Cancer Research Network · NCT03723928 Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Phase 3 · Smilow Cancer Hospital Care Center - Waterford · ECOG-ACRIN Cancer Research Group · NCT06475989

Look up another city

Look up another condition